The Global Influenza Diagnostics Market is projected to reach USD 1.1 billion by 2026 from USD 0.8billion in 2021, at a CAGR of 7.7% during the forecast period. Market growth is driven by factors such as the growth in influenza research for diagnostic technologies,rising demand for rapid disease diagnosis and increasing prevalence of influenza.